Anterior vs conventional approach hepatectomy for large liver cancer: A meta-analysis

Table 3 Characteristics of the included trials

Ref.	Design	Country	Patients, n (AAH/CAH)	Disease	Tumor size, cm (AAH/CAH)	Tumor≥5 cm
Lai et al[1]	CCT	China (Hong Kong)	25/34	HCC	12.8/8.4	85%
Liu et al[3]	CCT	China (Hong Kong)	54/106	HCC	10.3/10.5	100%
Liu et al[7]	RCT	China (Hong Kong)	60/60	HCC	10.5/10.0	100%
Takács et al[14]	CCT	Hungary	52/67	HCC or MHC	11.6/10.0	NR
Wang et al[15]	CCT	China (Taiwan)	14/11	HCC	12.5/12.0	100%
Wu et al[13]	CCT	China (Taiwan)	33/38	HCC	12.0/9.7	100%
Li et al[12]	CCT	China	92/96	HCC	12.2/10.4	100%
Capussotti et al[16]	RCT	Italy	33/32	HCC or MHC	6.0/5.2	NR

All values are means. AAH: Anterior approach hepatectomy; CAH: Conventional approach hepatectomy; CCT: Controlled clinical trial; HCC: Hepatocellular carcinoma; MHC: Metastatic hepatic carcinoma; NR: Not reported; RCT: Randomized controlled trial.